Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental peritoneal dialysis solutions

L Martis1, C Holmes, T Shockley

  • 1Renal Division Research, Baxter Healthcare Corporation, McGaw Park, Illinois 60085.

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic subglottic stenosis in Saskatchewan Hutterite population.

The Journal of laryngology and otology·2022
Same author

A case series of paediatric patients with spinal muscular atrophy type I undergoing scoliosis correction surgery.

Anaesthesia reports·2021
Same author

Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).

Thrombosis research·2021
Same author

Key Performance Indicators in Paediatric Anaesthesia

Irish medical journal·2019
Same author

Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?

Scandinavian journal of rheumatology·2018
Same author

A novel Alzheimer disease locus located near the gene encoding tau protein.

Molecular psychiatry·2015
Same journal

Translational insights into extracellular vesicles in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

Quercetin attenuates peritoneal fibrosis by upregulating ferroptosis-related glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) in MeT-5A and rat models: Supported by clinical mRNA expression data.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

An in vitro comparison of bacterial touch contamination prevention between a novel APD cycler connector and existing APD connectors.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

What is the effect of the assistance on the risk of transfer to HD after an unplanned peritoneal dialysis initiation? A cohort study with data from the RDPLF.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

2026 ISPD Position Statement on tracking and reporting loss from PD therapy.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

Important factors in the choice of dialysis modality among Japanese patients initiating peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
See all related articles

Researchers are exploring new peritoneal dialysis solutions with alternative osmotic agents and amino acids. These advancements aim to improve patient nutrition, manage lipid issues, and enhance fluid biocompatibility for better dialysis outcomes.

Area of Science:

  • Nephrology
  • Biochemistry
  • Biomaterials

Background:

  • Peritoneal dialysis (PD) solutions are critical for managing end-stage renal disease.
  • Current PD solutions primarily use dextrose as an osmotic agent, with potential drawbacks.
  • There is ongoing research into optimizing PD fluid composition.

Purpose of the Study:

  • To review literature on novel peritoneal dialysis solutions.
  • To explore alternative osmotic agents and amino acid-based solutions.
  • To highlight the importance of biocompatibility in PD fluid development.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of studies on peritoneal dialysis solution composition.
  • Synthesis of findings on osmotic agents, amino acids, and biocompatibility.

Related Experiment Videos

Main Results:

  • Glucose polymers and short-chain polypeptides show potential as dextrose substitutes.
  • Amino acid solutions offer nutritional benefits and can improve uremic lipid abnormalities.
  • Biocompatibility is a key focus in the development of next-generation PD fluids.

Conclusions:

  • Novel osmotic agents and amino acid-based solutions represent promising advancements in PD therapy.
  • Future PD solutions should prioritize both efficacy and biocompatibility for improved patient care.